Alena A. Kovaleva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alena A. Kovaleva has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Elena V. Sibirskaya
N.I. Pirogov Russian National Research Medical University, Russian Children’s Clinical Hospital (Branch)
4 shared publications - Irina V. Karachentsova
N.I. Pirogov Russian National Research Medical University, Russian Children’s Clinical Hospital (Branch)
3 shared publications - Polina O. Nikiforova
N.I. Pirogov Russian National Research Medical University, Russian Children’s Clinical Hospital (Branch)
3 shared publications - Aina S. Annakulieva
Russian Children’s Clinical Hospital
1 shared publication - Anastasia V. Timakova
I.M. Sechenov First Moscow State Medical University
1 shared publication - Asiyat D. Lepshokova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication
Latest Publications
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 32 (3)
Malignant neoplasms in pediatric gynecologist’s practice: a literature review
Objective. The aim of this review is to systematize and summarize current data on the problem of malignant neoplasms of the reproductive system in girls and adolescents. This draws attention to cancer awareness in the practice of pediatric gynecologist. It can improve the diagnosis, pathway and medical care of patients in this age group. Material and methods. A search and analysis of english literature was conducted using the PubMed, Embase, Cochrane Library and Google Scholar databases. The main attention is paid to scientific publications concerning the prevalence, variety, basic diagnostic methods, clinical manifestations and laboratory findings of malignant diseases in pediatric oncogynecology. Results. 13 case reports, 15 reviews, 4 series of case reports, 1 population-based retrospective cohort study, 1 multicenter retrospective study, 1 experimental preclinical study, 1 observational study and 1 prospective cohort study were identified. After analyzing these articles, they were included in the review. In 2022, there were 1 473 427 new cases of malignant neoplasms of the female reproductive system and 680 372 deaths. In children, gynecological malignancies account for 4.2% of all malignancies in girls aged 0 to 18 years. Conclusion. This article discusses the main types of malignant tumors occuring in childhood, including sarcomas, carcinomas, and rare cancers of breast, vagina and vulva. Many of the presented pathologies are extremely rare, so the importance of awareness of clinicians about malignant diseases occuring in practice of pediatric gynecologist to improve the results of early diagnosis and medical care.
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 32 (3)
Malignant neoplasms in pediatric gynecologist’s practice: a literature review
Objective. The aim of this review is to systematize and summarize current data on the problem of malignant neoplasms of the reproductive system in girls and adolescents. This draws attention to cancer awareness in the practice of pediatric gynecologist. It can improve the diagnosis, pathway and medical care of patients in this age group. Material and methods. A search and analysis of english literature was conducted using the PubMed, Embase, Cochrane Library and Google Scholar databases. The main attention is paid to scientific publications concerning the prevalence, variety, basic diagnostic methods, clinical manifestations and laboratory findings of malignant diseases in pediatric oncogynecology. Results. 13 case reports, 15 reviews, 4 series of case reports, 1 population-based retrospective cohort study, 1 multicenter retrospective study, 1 experimental preclinical study, 1 observational study and 1 prospective cohort study were identified. After analyzing these articles, they were included in the review. In 2022, there were 1 473 427 new cases of malignant neoplasms of the female reproductive system and 680 372 deaths. In children, gynecological malignancies account for 4.2% of all malignancies in girls aged 0 to 18 years. Conclusion. This article discusses the main types of malignant tumors occuring in childhood, including sarcomas, carcinomas, and rare cancers of breast, vagina and vulva. Many of the presented pathologies are extremely rare, so the importance of awareness of clinicians about malignant diseases occuring in practice of pediatric gynecologist to improve the results of early diagnosis and medical care.
- 24 June 2026
- Published by ECO-Vector LLC (Publications) in Journal of obstetrics and women's diseases
- Vol. 75 (3) , 94-103
Efficiency and safety of ovarian plasma therapy in patients with poor ovarian response and premature ovarian insufficiency: a systematic review
Despite growing clinical interest in the administration of autologous platelet-rich plasma (PRP) in primary ovarian insufficiency and diminished ovarian reserve, data on its efficacy remain extremely limited and methodologically heterogeneous. There are no standardized protocols, and the effect of therapy on key clinical outcomes has not been sufficiently studied. It is necessary to systematize the available data in order to assess the current level of evidence and identify areas for further research. The aim of the study was to evaluate the effectiveness of PRP therapy in women with poor ovarian response and primary ovarian insufficiency. This systematic review included English-language publications evaluating the effectiveness of PRP therapy in women with diminished ovarian reserve and primary ovarian insufficiency for the period 1985–2025. The review is based on the PRISMA checklist. Randomized and non-randomized original clinical trials (prospective, retrospective, quasi-experimental, etc.) were used for the analysis. After searching for and excluding duplicates, 415 articles were screened, of which 4 studies were selected for qualitative synthesis. The included studies demonstrate that intraovarian PRP administration can help improve biomarkers of ovarian reserve (anti-Müllerian hormone, follicle-stimulating hormone, and antral follicle count), particularly in patients with poor ovarian response syndrome and after surgery. A positive trend in pregnancy and live birth rates was noted, with no increase in the rates observed. PRP therapy demonstrates potential effectiveness in improving ovarian reserve parameters. However, due to the small number of studies, their heterogeneity and varying risk of systematic error, the impact on final reproductive outcomes requires further research. Large, randomized, controlled trials are needed to standardize PRP preparation and administration protocols and define clear indications for therapy.
- 24 June 2026
- Published by ECO-Vector LLC (Publications) in Journal of obstetrics and women's diseases
- Vol. 75 (3) , 94-103
Efficiency and safety of ovarian plasma therapy in patients with poor ovarian response and premature ovarian insufficiency: a systematic review
Despite growing clinical interest in the administration of autologous platelet-rich plasma (PRP) in primary ovarian insufficiency and diminished ovarian reserve, data on its efficacy remain extremely limited and methodologically heterogeneous. There are no standardized protocols, and the effect of therapy on key clinical outcomes has not been sufficiently studied. It is necessary to systematize the available data in order to assess the current level of evidence and identify areas for further research. The aim of the study was to evaluate the effectiveness of PRP therapy in women with poor ovarian response and primary ovarian insufficiency. This systematic review included English-language publications evaluating the effectiveness of PRP therapy in women with diminished ovarian reserve and primary ovarian insufficiency for the period 1985–2025. The review is based on the PRISMA checklist. Randomized and non-randomized original clinical trials (prospective, retrospective, quasi-experimental, etc.) were used for the analysis. After searching for and excluding duplicates, 415 articles were screened, of which 4 studies were selected for qualitative synthesis. The included studies demonstrate that intraovarian PRP administration can help improve biomarkers of ovarian reserve (anti-Müllerian hormone, follicle-stimulating hormone, and antral follicle count), particularly in patients with poor ovarian response syndrome and after surgery. A positive trend in pregnancy and live birth rates was noted, with no increase in the rates observed. PRP therapy demonstrates potential effectiveness in improving ovarian reserve parameters. However, due to the small number of studies, their heterogeneity and varying risk of systematic error, the impact on final reproductive outcomes requires further research. Large, randomized, controlled trials are needed to standardize PRP preparation and administration protocols and define clear indications for therapy.
- 17 March 2026
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 80 (6) , 405-419
Surgical and non-surgical methods of creation of a neovagina in patients with Mayer–Rokitansky–Kuster–Hauser syndrome: a systematic review
To study the effectiveness of surgical and non-surgical methods of vaginoplasty in patients with Mayer–Rokitansky–Kuster–Hauser syndrome by comparing themselves. This systematic review includes all publications in English about studies that which compare non-surgical vaginoplasty methods with surgical ones and surgical methods between themselves for the period 1975–2023. The review is written according to the PRISMA checklist. Randomized and non-randomized original clinical trials (comparative retrospective, randomized controlled, retrospective, etc.) were used for the analysis. After searching for and eliminating duplicates, 780 articles were screened, 739 of which were excluded for mismatching titles and abstracts. As a result, 23 studies were selected for qualitative synthesis. Taking into account the experience of clinical use and scientific and practical data, it can be noted the first-choice treatment should begin with non-surgical methods, but besides them, there are many options for surgical vaginoplasty methods using intestinal segments, a segment of the peritoneum, amnion, skin grafts, autologous vaginal tissue cultured in vitro, etc. Thus, there is a need for more randomized controlled trials comparing various methods of creating a neovagina in patients with Mayer–Rokitansky–Kuster–Hauser syndrome.
- 17 March 2026
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 80 (6) , 405-419
Surgical and non-surgical methods of creation of a neovagina in patients with Mayer–Rokitansky–Kuster–Hauser syndrome: a systematic review
To study the effectiveness of surgical and non-surgical methods of vaginoplasty in patients with Mayer–Rokitansky–Kuster–Hauser syndrome by comparing themselves. This systematic review includes all publications in English about studies that which compare non-surgical vaginoplasty methods with surgical ones and surgical methods between themselves for the period 1975–2023. The review is written according to the PRISMA checklist. Randomized and non-randomized original clinical trials (comparative retrospective, randomized controlled, retrospective, etc.) were used for the analysis. After searching for and eliminating duplicates, 780 articles were screened, 739 of which were excluded for mismatching titles and abstracts. As a result, 23 studies were selected for qualitative synthesis. Taking into account the experience of clinical use and scientific and practical data, it can be noted the first-choice treatment should begin with non-surgical methods, but besides them, there are many options for surgical vaginoplasty methods using intestinal segments, a segment of the peritoneum, amnion, skin grafts, autologous vaginal tissue cultured in vitro, etc. Thus, there is a need for more randomized controlled trials comparing various methods of creating a neovagina in patients with Mayer–Rokitansky–Kuster–Hauser syndrome.
- Open Access
- 15 July 2025
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 22 (3) , 308-314
46,XX Testicular Disorders of Sex Development: Case Report
Background. The article presents a rare case report of sex development disorder (DSDs, 46-XX-male), demonstrating the need for timely diagnosis, conservative and surgical treatment, and emphasizes the importance of a multidisciplinary approach. Due to the low frequency of occurrence of this pathology at an early age, the description of a new case is of undoubted interest and scientific and practical significance.Case Repot. A case report of a 12-year-old female patient diagnosed with 46,XX testicular disorder of sex development is presented. The stages of the diagnostic search, treatment methods depending on age, course of the disease, and response to therapy are described.Conclusion. Patients diagnosed with disorders of sex development are recommended to be constantly monitored by doctors in order to prescribe and correct conservative therapy, resolve issues about surgical treatment methods, improve the quality of life and implement reproductive function.
- 15 July 2025
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 22 (3) , 308-314
Open Access46,XX Testicular Disorders of Sex Development: Case Report
Background. The article presents a rare case report of sex development disorder (DSDs, 46-XX-male), demonstrating the need for timely diagnosis, conservative and surgical treatment, and emphasizes the importance of a multidisciplinary approach. Due to the low frequency of occurrence of this pathology at an early age, the description of a new case is of undoubted interest and scientific and practical significance.Case Repot. A case report of a 12-year-old female patient diagnosed with 46,XX testicular disorder of sex development is presented. The stages of the diagnostic search, treatment methods depending on age, course of the disease, and response to therapy are described.Conclusion. Patients diagnosed with disorders of sex development are recommended to be constantly monitored by doctors in order to prescribe and correct conservative therapy, resolve issues about surgical treatment methods, improve the quality of life and implement reproductive function.